Pfizer Inc. (PFE)
27.90
-0.12
(-0.43%)
USD |
NYSE |
Aug 28, 15:41
Pfizer Debt to Equity Ratio : 0.7418 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7418 |
| March 31, 2026 | 0.7154 |
| December 31, 2025 | 0.7796 |
| September 30, 2025 | 0.665 |
| June 30, 2025 | 0.6967 |
| March 31, 2025 | 0.6875 |
| December 31, 2024 | 0.7595 |
| September 30, 2024 | 0.7336 |
| June 30, 2024 | 0.7919 |
| March 31, 2024 | 0.7535 |
| December 31, 2023 | 0.843 |
| September 30, 2023 | 0.6561 |
| June 30, 2023 | 0.6599 |
| March 31, 2023 | 0.3555 |
| December 31, 2022 | 0.4082 |
| September 30, 2022 | 0.3959 |
| June 30, 2022 | 0.4619 |
| March 31, 2022 | 0.4404 |
| December 31, 2021 | 0.5362 |
| September 30, 2021 | 0.5269 |
| June 30, 2021 | 0.5603 |
| March 31, 2021 | 0.5785 |
| December 31, 2020 | 0.6525 |
| September 30, 2020 | 0.9677 |
| June 30, 2020 | 0.9888 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8041 |
| December 31, 2019 | 0.8469 |
| September 30, 2019 | 0.8291 |
| June 30, 2019 | 0.8052 |
| March 31, 2019 | 0.7897 |
| December 31, 2018 | 0.6583 |
| September 30, 2018 | 0.5754 |
| June 30, 2018 | 0.5807 |
| March 31, 2018 | 0.5819 |
| December 31, 2017 | 0.6099 |
| September 30, 2017 | 0.7232 |
| June 30, 2017 | 0.7488 |
| March 31, 2017 | 0.7531 |
| December 31, 2016 | 0.7068 |
| September 30, 2016 | 0.6961 |
| June 30, 2016 | 0.7039 |
| March 31, 2016 | 0.6242 |
| December 31, 2015 | 0.6023 |
| September 30, 2015 | 0.582 |
| June 30, 2015 | 0.5251 |
| March 31, 2015 | 0.5338 |
| December 31, 2014 | 0.5145 |
| September 30, 2014 | 0.4751 |
| June 30, 2014 | 0.4936 |
| March 31, 2014 | 0.4754 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Merck & Co., Inc. | 1.286 |
| Bristol Myers Squibb Co. | 2.019 |
| Viatris, Inc. | 0.9555 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 201.13B |
| Total Liabilities (Quarterly) | 115.64B |
| Shareholders Equity (Quarterly) | 85.19B |
| Current Ratio | 1.267 |
| Net Debt Paydown Yield | -0.16% |